Rebecca R. Andridge, PhD

Andridge
Assistant Professor
Biostatistics

320 W. 10th Ave.
B-116 Starling Loving Hall
Columbus, OH 43210
Send Email
Phone: (614) 293-3925

 

Education

PhD, Biostatistics, University of Michigan, 2009
MS, Biostatistics, University of Michigan, 2005
BA, Economics, Stanford University, 1999

Appointments

Member, American Statistical Association
Member, International Biometric Society (Eastern North American Region)

 

Research

Dr. Andridge's research interests include developing and evaluating statistical methods for handling missing data and for group-randomized trials.

 

Honors/Awards

Rackham Predoctoral Fellowship, UM Rackham Graduate School, Fall 2008-Summer 2009

Travel Grant, UM Rackham Graduate School, Summer 2008

Travel Award, Survey Research Methods Section, ASA, Summer 2008

NIH Predoctoral Cancer Research Training Grant, UM Department of Biostatistics, Fall 2005-Fall 2008

 

2008 Publications

Soto DE, Glaser S, Roberts RH, Schipper MJ, McLaughlin PW, Ray ME, Sandler HM, Pan CC (2008). Impact of common iliac nodal treatment on radiation outcomes in localized prostate cancer. Urology 71; 313-317.

Soto DE, Andridge RR, Pan CC, Williams SG, Taylor JMG, Sandler HM (2008). In patients experiencing biochemical failure after radiation therapy, pretreatment risk group and PSA velocity predict differences in overall survival and biochemical failure-free interval. International Journal of Radiation Oncology, Biology, Physics 71; 1295-1301.

Soto DE, Andridge RR, Taylor JMG, McLaughlin PW, Sandler HM, Pan CC (2008). Predicting biochemical failure and overall survival through intra-therapy PSA changes during definitive external beam radiation. International Journal of Radiation Oncology, Biology, Physics 72; 1408-1415.

Soto DE, Andridge R, Pan CC, Williams S, Taylor J, Sandler HM (2008). Determining if pretreatment PSA doubling time predicts PSA trajectories after radiation therapy for localized prostate cancer. Radiotherapy and Oncology 90; 389-394.

Taylor JMG, Ankerst DP, Andridge RR (2008). Validation of biomarker-based risk prediction models. Clinical Cancer Research 14; 5977-5983.

 

2007 Publications

Profit J, McCormick MC, Escobar GJ, Richardson DK, Zheng Z, Coleman-Phox K, Roberts R, Zupancic JAF (2007). Neonatal intensive care unit census influences discharge of moderately preterm infants. Pediatrics 119; 314-319.

Lee IH, Roberts R, Shah RB, Wojno KJ, Wei JT, Sandler HM (2007). Perineural invasion is a marker for pathologically advanced disease in localized prostate cancer. International Journal of Radiation Oncology, Biology, Physics 68; 1059-1064.